STERIS is trading roughly flat as the stock continues to face pressure from a broader market downturn that saw the S&P 500 shed 0.22% and the Dow Jones Industrial Average lose 341.41 points on October 7. While the company has maintained double-digit EPS growth, investor sentiment remains tempered by a reduced free-cash-flow outlook and higher capital spending requirements. These fundamental headwinds, combined with the stock lagging behind its healthcare peers, have kept the shares trading 6.2% below their 50-day moving average.